BPC-157 and thymosin beta 4 dosage is not standardized; here is what research studies report, how doses are measured, and why human use remains unapproved.
There is no FDA-approved or standardized dosage for BPC-157 and thymosin beta 4 in humans. Every number that circulates online traces back to rodent studies, veterinary use, or anecdotal reports from people self-administering gray-market peptides. That means there is no reliable human dose to copy, and anyone considering these compounds should talk with a licensed healthcare professional first.
What BPC-157 and Thymosin Beta 4 Are
BPC-157 is a synthetic peptide made of 15 amino acids. It was originally isolated from human gastric juice and has been studied in animals for its effects on tendon, ligament, gut, and vascular tissue.
Thymosin beta 4 is a larger, naturally occurring protein found in most human cells, where it helps regulate actin and cell migration. The product sold as TB-500 is a shorter synthetic fragment of thymosin beta-4, which is why the two names are often used interchangeably in dosing discussions.
Neither compound is a dietary supplement, and neither has an approved human dose. BPC-157 is not FDA-approved for human use in the United States, and thymosin beta 4 is not approved as a drug for human use either.
Typical BPC-157 and Thymosin Beta 4 Dosage Ranges in Research
Doses in published animal studies are usually expressed per kilogram of body weight, which makes them difficult to translate into a human protocol. The table below summarizes the ranges that appear most often in the literature and in community discussions.
| Compound | Route studied | Reported range | Reported frequency |
|---|---|---|---|
| BPC-157 (animal studies) | Subcutaneous, intraperitoneal, oral | 10-100 mcg/kg per day | Once or twice daily |
| BPC-157 (community reports) | Subcutaneous | 200-500 mcg per dose | Once or twice daily |
| Thymosin beta 4 / TB-500 (animal studies) | Subcutaneous, intramuscular | Often reported in mg/kg | Every other day to twice weekly |
| Thymosin beta 4 / TB-500 (community reports) | Subcutaneous | 2-5 mg per dose | Once or twice weekly |
The community numbers above are anecdotal. They are not derived from controlled human trials, and no regulatory body has reviewed them for safety or effectiveness.
Body weight changes the math dramatically. A bpc-157 dosage chart by weight is a common reference point, but most of the weight-based data comes from rodents, so scaling it directly to a person is not scientifically valid.
How to Calculate a Dose From a Vial
Most peptide vials are sold as lyophilized powder and must be reconstituted with bacteriostatic water before any measurement is possible. Concentration equals the total peptide in the vial divided by the milliliters of diluent added.
| Vial size | Diluent added | Concentration | Volume for a 250 mcg dose | Units on a U-100 syringe |
|---|---|---|---|---|
| 5 mg | 2 mL | 2.5 mg/mL | 0.10 mL | 10 units |
| 5 mg | 1 mL | 5 mg/mL | 0.05 mL | 5 units |
| 10 mg | 2 mL | 5 mg/mL | 0.05 mL | 5 units |
| 10 mg | 1 mL | 10 mg/mL | 0.025 mL | 2.5 units |
A bpc-157 and tb-500 dosage calculator can handle this arithmetic, but a calculator cannot tell you whether a dose is appropriate, safe, or legal. Always read the concentration on your own vial instead of trusting a generic tool.
BPC-157 vs Thymosin Beta 4: Practical Differences
- Size and structure: BPC-157 is a short 15-amino-acid peptide, while thymosin beta 4 is a full-length protein and TB-500 is a fragment of it.
- Dose scale: BPC-157 is typically discussed in micrograms, while thymosin beta 4 and TB-500 are discussed in milligrams.
- Frequency: BPC-157 protocols are usually described as daily or twice daily, while TB-500 is usually described as less frequent.
- Research focus: BPC-157 has been studied heavily in gastrointestinal and musculoskeletal animal models, while thymosin beta 4 has been studied in cardiac and wound-healing models.
People searching for a bpc-157 and tb-500 dosage for injury are usually looking at a stacked protocol, which combines two unapproved compounds and multiplies the unknowns. Stacking questions such as bpc 157 and cjc 1295 involve a different peptide with its own dosing logic and should be evaluated separately.
Safety, Legality, and Product Quality
In the United States, BPC-157 and thymosin beta 4 are not approved for human use and cannot legally be sold as dietary supplements. They are frequently marketed as research chemicals or labeled "not for human consumption," which shifts legal responsibility to the buyer.
Product quality is a real risk. Independent testing has repeatedly found that gray-market peptide vials are sometimes underdosed, mislabeled, or contaminated, which makes any dose calculation meaningless. Questions about where to buy bpc-157 and tb-500 usually lead to vendors with no pharmacy oversight, no chain of custody, and no guarantee of sterility.
Reported problems from self-administered peptides include injection-site reactions, inflammation, and unpredictable systemic effects. Sterile technique matters, and sharing vials or needles carries an infection risk.
What to Ask a Healthcare Professional
If you are considering these compounds, bring the question to a physician, pharmacist, or sports medicine clinician rather than to a vendor. Useful questions include:
- Are there approved treatments for my condition that we should try first?
- What are the documented risks of injectable peptides for someone with my health history?
- Could this interact with medications I already take?
- Are there clinical trials I could join instead of self-dosing?
No dose of BPC-157 or thymosin beta 4 has been proven safe or effective in humans through large controlled trials. Until that changes, the most defensible position is caution, honesty with your clinician, and skepticism toward any protocol that promises one specific number.
Frequently Asked Questions
What is a typical BPC-157 and thymosin beta 4 dosage?
There is no standard or approved dosage for either compound in humans. Animal studies report BPC-157 around 10-100 mcg/kg and thymosin beta 4 in mg/kg ranges, while online community protocols usually mention 200-500 mcg of BPC-157 per dose and 2-5 mg of TB-500 per dose. Those community numbers are anecdotal and have not been validated in controlled human trials, so they should not be treated as a safe target.
Do you calculate BPC-157 dosing by body weight?
Weight-based dosing comes almost entirely from rodent research, where doses are given in micrograms per kilogram. Human community protocols typically use a fixed dose per injection instead, and no weight-based chart has been validated for people. Because of that gap, a body-weight chart should be viewed as a research reference rather than a dosing guide.
Is BPC-157 or thymosin beta 4 legal to buy in the United States?
Neither peptide is FDA-approved for human use, and neither can legally be sold as a dietary supplement. They are commonly marketed as research chemicals labeled not for human consumption, and importing them for personal use may violate federal rules. State laws also vary, so check with a licensed professional before assuming any product is legitimate.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.